ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Pharmacokinetic interactions between Hypericm perforatum L. and conventional drugs

Pharma Middle East

Roja Rahimi and Mohammad Abdollahi

Tehran University of Medical Sciences, Iran

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Introduction: Hypericum perforatum, more commonly known as St. John�s wort, is a recognized medicinal plant with recognized antidepressant properties. It affects the pharmacokinetics of many drugs by inducing cytochromeP450 (CYP) isozymes and the P-glycoprotein (P-gp) transporter. This review focuses on drugs that their pharmacokinetics affected by this medicinal plant. Method: All electronic databases such as PubMed, Scopus, Google Scholar and Cochrane library were searched to identify in vitro, in vivo or human studies about the effects of Hypericum perforatum on the metabolism of drugs. Data collected were published between 1966 and January 2012. Results: There are a number of drugs whose metabolism affected by Hypericum perforatum including amitryptillin, docetaxol, digoxin, bupropion, oral contraceptives, fexofenadin, verapamil, immune-suppressants and warfarin. The metabolic interactions between Hypericum perforatum and drugs are not always unfavorable and sometimes have benefits (e.g., reduction of irinotecan toxicity and increase in clopidogrel responsiveness).The pharmacokinetics of some drugs does not affect by Hypericum perforatum, although they are metabolized by Hypericum perforatum-targetted cytochromes. Carbamazepine, ibuprofen and theophylline are examples of these drugs. Conclusion: The use of Hypericum perforatum preparations is not recommended in patients who are taking immune-suppressants or cardiovascular drugs. With other medications, it is recommended that practitioners should only use preparations with low hyperforin content and under careful monitoring. Because of the reduction in the bioavailability of oral contraceptives, women who use Hypericum perforatum preparations should use additional preventive methods to avoid unintended pregnancy.
Biography

Roja Rahimi has completed her PhD in the year 2012 from Tehran University of Medical Sciences and she is now an Assistant Professor at School of Traditional Pharmacy of Tehran University of Medical Sciences. She has published more than 70 papers in reputed journals and has been serving as an Editorial Board Member of 6 international journals. Her H-index is 26. Her research interests are discovery of pharmacological mechanisms and pathways of natural products, evaluation of efficacy and safety of natural products, and formulation and standardization of natural medicines.

Email: rahimi_r@tums.ac.ir

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top